Technical Analysis for CSBR - Champions Oncology, Inc.

Grade Last Price % Change Price Change
grade D 10.61 4.74% 0.48
CSBR closed up 4.74 percent on Monday, March 18, 2019, on 40 percent of normal volume.

Earnings due: Mar 20

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CSBR trend table...

Date Alert Name Type % Chg
Mar 18 180 Bullish Setup Bullish Swing Setup 0.00%
Mar 18 Outside Day Range Expansion 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 15 MACD Bullish Centerline Cross Bullish 4.74%
Mar 15 MACD Bullish Signal Line Cross Bullish 4.74%
Mar 15 Wide Bands Range Expansion 4.74%
Mar 14 50 DMA Support Bullish 4.64%
Mar 14 Multiple of Ten Bullish Other 4.64%
Mar 14 Wide Bands Range Expansion 4.64%
Mar 14 Up 3 Days in a Row Strength 4.64%

Older signals for CSBR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that uses vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.
Bank Health Biotechnology Cancer Technology Solutions Tumor Drug Development Tumors Cancer Care Basilea Pharmaceutica Patient's Tumor
Is CSBR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.9
52 Week Low 3.25
Average Volume 64,570
200-Day Moving Average 9.6802
50-Day Moving Average 10.0175
20-Day Moving Average 9.8295
10-Day Moving Average 9.991
Average True Range 0.7052
ADX 15.78
+DI 24.2514
-DI 17.4335
Chandelier Exit (Long, 3 ATRs ) 9.8244
Chandelier Exit (Short, 3 ATRs ) 10.335600000000001
Upper Bollinger Band 11.47
Lower Bollinger Band 8.189
Percent B (%b) 0.74
BandWidth 33.379114
MACD Line 0.0529
MACD Signal Line 0.0047
MACD Histogram 0.0483
Fundamentals Value
Market Cap 116.54 Million
Num Shares 11 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -23.07
Price-to-Sales 2.13
Price-to-Book 125.38
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.51
Resistance 3 (R3) 11.42 11.03 11.36
Resistance 2 (R2) 11.03 10.80 11.08 11.31
Resistance 1 (R1) 10.82 10.66 10.93 10.91 11.26
Pivot Point 10.43 10.43 10.48 10.48 10.43
Support 1 (S1) 10.22 10.20 10.33 10.31 9.96
Support 2 (S2) 9.83 10.06 9.88 9.91
Support 3 (S3) 9.62 9.83 9.86
Support 4 (S4) 9.71